End-of-day quote
Shanghai S.E.
18:00:00 2024-05-12 EDT
|
5-day change
|
1st Jan Change
|
1.88
CNY
|
-2.59%
|
|
-8.29%
|
-30.11%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,448
|
3,838
|
2,198
|
3,417
|
2,945
|
2,085
|
Enterprise Value (EV)
1 |
3,467
|
4,016
|
2,279
|
3,515
|
3,044
|
2,119
|
P/E ratio
|
-6.81
x
|
-49.2
x
|
23.8
x
|
88.2
x
|
-5.94
x
|
-53.8
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
13.8
x
|
11.5
x
|
6.61
x
|
9.43
x
|
7.81
x
|
7.03
x
|
EV / Revenue
|
13.9
x
|
12.1
x
|
6.85
x
|
9.69
x
|
8.07
x
|
7.15
x
|
EV / EBITDA
|
-56.6
x
|
540
x
|
40.9
x
|
53.1
x
|
76.4
x
|
-1,305
x
|
EV / FCF
|
-37.3
x
|
-52.6
x
|
322
x
|
-469
x
|
45.9
x
|
23.2
x
|
FCF Yield
|
-2.68%
|
-1.9%
|
0.31%
|
-0.21%
|
2.18%
|
4.3%
|
Price to Book
|
3.82
x
|
5.09
x
|
2.63
x
|
3.9
x
|
8.95
x
|
7.07
x
|
Nbr of stocks (in thousands)
|
780,000
|
780,000
|
776,804
|
774,920
|
774,920
|
774,920
|
Reference price
2 |
4.420
|
4.920
|
2.830
|
4.410
|
3.800
|
2.690
|
Announcement Date
|
4/19/19
|
4/28/20
|
4/27/21
|
4/27/22
|
8/30/23
|
4/26/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
249
|
332.6
|
332.7
|
362.6
|
377.2
|
296.3
|
EBITDA
1 |
-61.25
|
7.443
|
55.79
|
66.16
|
39.87
|
-1.624
|
EBIT
1 |
-71.54
|
-6.673
|
38.62
|
49.29
|
26.54
|
-18.2
|
Operating Margin
|
-28.73%
|
-2.01%
|
11.61%
|
13.59%
|
7.04%
|
-6.14%
|
Earnings before Tax (EBT)
1 |
-513.4
|
-88.16
|
102.1
|
42.7
|
-481.5
|
-30.36
|
Net income
1 |
-506
|
-77.79
|
92.67
|
37.18
|
-498.4
|
-35.08
|
Net margin
|
-203.2%
|
-23.39%
|
27.85%
|
10.25%
|
-132.15%
|
-11.84%
|
EPS
2 |
-0.6490
|
-0.1000
|
0.1190
|
0.0500
|
-0.6400
|
-0.0500
|
Free Cash Flow
1 |
-92.89
|
-76.41
|
7.071
|
-7.495
|
66.27
|
91.22
|
FCF margin
|
-37.3%
|
-22.97%
|
2.13%
|
-2.07%
|
17.57%
|
30.78%
|
FCF Conversion (EBITDA)
|
-
|
-
|
12.68%
|
-
|
166.23%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
7.63%
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/19/19
|
4/28/20
|
4/27/21
|
4/27/22
|
8/30/23
|
4/26/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
19.4
|
179
|
80.9
|
97.5
|
99.7
|
34.4
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-0.317
x
|
24
x
|
1.45
x
|
1.473
x
|
2.502
x
|
-21.2
x
|
Free Cash Flow
1 |
-92.9
|
-76.4
|
7.07
|
-7.49
|
66.3
|
91.2
|
ROE (net income / shareholders' equity)
|
-38.5%
|
-7.98%
|
11.4%
|
4.53%
|
-80.2%
|
-8.99%
|
ROA (Net income/ Total Assets)
|
-2.42%
|
-0.29%
|
1.78%
|
2.33%
|
1.49%
|
-1.34%
|
Assets
1 |
20,905
|
26,578
|
5,202
|
1,597
|
-33,548
|
2,623
|
Book Value Per Share
2 |
1.160
|
0.9700
|
1.080
|
1.130
|
0.4200
|
0.3800
|
Cash Flow per Share
2 |
0.2800
|
0.2300
|
0.1500
|
0.2100
|
0.2100
|
0.2100
|
Capex
1 |
81.1
|
56.6
|
31.1
|
10.5
|
25.8
|
9.55
|
Capex / Sales
|
32.57%
|
17.01%
|
9.35%
|
2.9%
|
6.84%
|
3.22%
|
Announcement Date
|
4/19/19
|
4/28/20
|
4/27/21
|
4/27/22
|
8/30/23
|
4/26/24
|
|
1st Jan change
|
Capi.
|
---|
| -30.11% | 207M | | +17.10% | 8.43B | | +14.30% | 6.82B | | -3.69% | 3.77B | | -7.34% | 3.74B | | +1.78% | 1.44B | | -28.77% | 1.06B | | +18.84% | 1.04B | | -11.81% | 890M | | -18.34% | 812M |
Special Foods & Wellbeing Products
|